New York, NY, September 16, 2022 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced today that it has completed an investment in Third Wave Recovery Systems, LLC (“TWRx” or the “Company”), a provider of rebate administration services for hospitals, long-term care (LTC) facilities, and select specialty physician groups. Terms … Read More
New York, NY, August 3, 2022 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced today that it has completed its strategic investment in BPD, LLC (“BPD” or the “Company”), a hospital- and health system-focused provider of data-driven marketing solutions. Hospitals and health systems engage BPD to develop brand strategy, … Read More
New York, NY, July 27, 2022 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced today that it has completed the recapitalization of RevHealth, LLC (or the “Company”), a science-focused independent provider of omnichannel healthcare communications, supporting pharma, biotech, device, and other healthcare clients with professional promotion, medical education, and … Read More
New York, NY, February 15, 2022 — WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that Mitchell Daitz, a highly successful healthcare CEO and entrepreneur, has joined WindRose as an Operating Partner. In that role, he will assist WindRose in the evaluation of healthcare investments and work with portfolio companies … Read More
New York, NY (January 6, 2022) – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced today that it has completed the sale of basys, LLC (“basys”) to BPOC and Five Arrows Capital. Following the sale, basys merged with Innovative Software Solutions Inc. (“ISSI”) to form a leading multiemployer benefits administration … Read More
New York, NY (January 5, 2022) – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of Terrapin Pharmacy LLC (“Terrapin” or the “Company”), a leading specialized pharmacy offering high-touch, value-added distribution and medication adherence services and technology. The Company primarily serves patients with severe … Read More
New York, NY, November 22, 2021 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of StateServ Medical (“StateServ” or the “Company”), the leading provider of durable medical equipment (“DME”) benefit management solutions to the post-acute care market in the United States. Through a … Read More
Investment to accelerate Workplace Options’ strategy of rapid growth and innovation Raleigh, NC (November 1, 2021) – Workplace Options (WPO), a leading independent wellbeing provider headquartered in Raleigh, NC, announced today it has entered into a definitive agreement with WindRose Health Investors, LLC, (“WindRose”) a private equity firm specializing in healthcare. Workplace Options is responsible … Read More
(New York, NY) October 6, 2021 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced today that it has completed the sale of Vital Decisions, LLC (“Vital Decisions” or the “Company”) to Evolent Health, Inc. (“Evolent Health”). Vital Decisions will report into Evolent’s specialty management offering, New Century Health, and … Read More
(New York, NY) August 2, 2021 – Bluestone Physician Services (“Bluestone” or the “Company”), a portfolio company of WindRose Health Investors, LLC (“WindRose”), announced today that it has received a strategic investment from the Blue Venture Fund (“BVF”), a unique collaboration among Blue Cross and Blue Shield (BCBS) companies, Blue Cross Blue Shield Association (BCBSA), … Read More
(New York, NY) July 14, 2021 – Kolmac Outpatient Recovery Centers (“Kolmac”) announced today that it has completed a merger with Concerted Care Group (“CCG”). Through the combination with CCG, Kolmac, which has historically focused on serving the working insured population, expands its services to treat all individuals, regardless of insurance type, with a continued … Read More
(New York, NY) April 29, 2021 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the sale of myNEXUS, Inc. (“myNEXUS” or the “Company”), to Anthem, Inc. (“Anthem”). Terms of the transaction were not disclosed. myNEXUS is a post-acute benefit management company helping its payor clients … Read More
(New York, NY) April 14, 2021 – WindRose Health Investors, LLC (“WindRose”), a healthcare-focused private equity firm, announced the completion of an equity recapitalization of Bluestone Physician Services (“Bluestone” or the “Company”). Bluestone provides an integrated care delivery model to more than 22,000 high-risk, chronically ill patients residing in senior living, community, and other home-based … Read More
(New York, NY) April 7, 2021 – WindRose Health Investors, LLC (“WindRose”), a New York City-based healthcare private equity firm, announced the completion of an equity recapitalization of Veristat Group Inc. (“Veristat” or the “Company”). Veristat is a scientifically minded global clinical research organization (CRO) that empowers biotech and pharmaceutical sponsors to advance complex therapeutic … Read More
New York, NY, July 28, 2020 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of Caregiver Inc. (“Caregiver” or the “Company”), a leading provider of long-term care services and supports to people with intellectual and developmental disabilities. Terms of the transaction were not … Read More
(New York, NY) January 13, 2020 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the sale of substantially all of the assets of its portfolio company, Trust Healthcare Consulting Services, LLC (“TrustHCS” or the “Company”), to a healthcare joint venture established by an affiliate of … Read More
(New York, NY) January 8, 2020 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of its portfolio company, Medical Knowledge Group, LLC (“Medical Knowledge Group” or the “Company”), by investment funds managed by Court Square Capital Partners (“Court Square”). Terms of the transaction … Read More
(New York, NY) June 17, 2019 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of its portfolio company, Ovation Fertility (“Ovation”), by investment funds managed by Morgan Stanley Capital Partners (“MSCP”). Terms of the transaction were not disclosed. Ovation is a leading provider … Read More
(New York, NY) June 4, 2019 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced the completion of an equity recapitalization of Lykan Bioscience Holdings, LLC (“Lykan” or the “Company”). Lykan is a manufacturing services organization focused on providing outsourced end-to-end production and logistics solutions for pharmaceutical and biotech companies … Read More
(New York, NY) May 21, 2019 – WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced the completion of an equity recapitalization of Healthmap Solutions, Inc. (“Healthmap” or the “Company”) with a commitment of $85 million. Healthmap is a specialty health management company focused on progressive diseases, with particular expertise in … Read More
New York, NY – WindRose Health Investors, LLC (“WindRose”), the healthcare-focused private equity fund, has closed its fifth fund, WindRose Health Investors V, L.P. (“Fund V”) with $705 million in limited partner and general partner commitments. The fund was over-subscribed and closed at its fundraising cap. WindRose Managing Partner, Oliver T. Moses, said, “It is … Read More
(New York, NY) November 14, 2018 – WindRose Health Investors, LLC (“WindRose”), a healthcare-focused private equity firm, announced that funds managed by WindRose have completed a recapitalization of Traditions Behavioral Health (“TBH”), a West Coast-based provider of permanent outsourced physician psychiatric services to institutional and community-based programs. TBH’s permanent staffing solution addresses the serious difficulties … Read More
WindRose Health Investors, LLC (“WindRose”), a healthcare-focused private equity firm, announced that funds managed by WindRose have completed a recapitalization of Kolmac Clinic, LLC (“Kolmac”), an East Coast-based outpatient addiction treatment company. Kolmac provides evidence-based outpatient addiction treatment that combines psychosocial services with medication assisted therapy to effectively treat a patient’s substance use disorder and … Read More
WindRose Health Investors, LLC (“WindRose”), a healthcare-focused private equity firm, announced that funds managed by WindRose have completed a recapitalization of basys, LLC (“basys”). basys is a leading provider of benefits administration technology for the Taft-Hartley market that employs more than 130 people in the Baltimore area. Terms of the transaction were not disclosed. Through … Read More
MTS Health Investors, LLC, the New York-based private equity firm, is pleased to announce that it has rebranded as WindRose Health Investors, LLC. The firm shares a common lineage with leading healthcare investment bank, MTS Health Partners, L.P., and therefore inherited a similar name. However, the two businesses are independent and have operated separately for … Read More
(New York, NY) – MTS Health Investors, LLC (“MTS”), a healthcare-focused private equity firm, announced that its portfolio company Celerion Holdings, Inc. (“Celerion”) has partnered with Court Square Capital Partners (“Court Square”). Court Square is investing in partnership with the Celerion management team, who will continue to own a minority interest in the Company. Terms … Read More
(New York, NY) September 8, 2017 – MTS Health Investors, LLC (“MTS”), a healthcare-focused private equity firm, announced that it has completed the sale of its portfolio company, Woodbury Holdings (“Woodbury”), to ConvaTec Group Plc (“ConvaTec”, LON:CTEC). Terms of the transaction were not disclosed. Based in Floral Park, NY, Woodbury provides an extensive array of … Read More
NEW YORK, August 9, 2017 — MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced that funds managed by MTS have completed a recapitalization of Medical Knowledge Group, LLC (“Medical Knowledge Group” or the “Company”). Headquartered in New York City, Medical Knowledge Group is an analytics-driven and technology-enabled multi-channel healthcare marketing … Read More
NEW YORK, August 2, 2017 — MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced that funds managed by MTS have completed an investment in Accuity Delivery Systems LLC (“Accuity” or the “Company”). Terms of the transaction were not disclosed. Accuity is a revenue cycle management business that provides clinical documentation … Read More
NEW YORK — MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced that funds managed by MTS have completed a recapitalization of Trumpet Behavioral Health, LLC (“Trumpet” or the “Company”). Trumpet is a leading provider of behavioral health services, specializing in the treatment of children, adolescents, and adults with Autism Spectrum … Read More
New York, October 5, 2016 — MTS Health Investors, LLC (“MTS”), the healthcare-focused private equity fund, announced today the closing of its fourth fund, MTS Health Investors IV, L.P. (“Fund IV”) with $365 million in limited partner and general partner commitments. The fund was oversubscribed and closed at its fundraising cap. Senior Managing Director, Curtis … Read More
NEW YORK — MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced that funds managed by MTS have completed the recapitalization of Avadyne Health (“Avadyne” or the “Company”). Avadyne is a provider of outsourced revenue cycle services and proprietary workflow software solutions. The Company combines patient-centric revenue cycle expertise with technology … Read More
Floral Park, NY – April 8, 2016 –Woodbury Health Products Inc. (“Woodbury”) announced today that its affiliate, Wilmington Medical Supply, Inc., has acquired certain assets from Advanced Medical Group, LLC (“AMG”), a Southeastern United States distributor of home urological supplies. Woodbury is owned by funds managed by MTS Health Investors, LLC, (“MTS”) a New York-based … Read More
NEWPORT BEACH, CA — March 29, 2016 — Alliance HealthCare Services, Inc. (NASDAQ: AIQ) (the “Company”, “Alliance”, “we” or “our”), a leading national provider of outsourced radiology, oncology and interventional services, announced today that the Company entered into a Governance, Voting and Standstill Agreement (the “Governance Agreement”) with Fujian Thai Hot Investment Co., Ltd (“Fujian … Read More
NASHVILLE, TN and NEW YORK, NY, January 8, 2016 – HCCA Health Connections, Inc. and HCCA International, Inc. (collectively known as “HCCA”) and MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced that funds managed by MTS have completed a strategic equity investment in HCCA. Through this transaction, MTS has partnered … Read More
NEW YORK, October 13, 2015 — MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced today that it has successfully completed the sale of its portfolio company, DNA Diagnostics Center (“DDC” or the “Company”), to GHO Capital for $110 million. DDC is a market leading diagnostics business and is one of … Read More
NEW YORK, September 29, 2015 — MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced that funds managed by MTS have completed a strategic equity investment in Trust Healthcare Consulting Services, LLC (“TrustHCS” or the “Company”). TrustHCS is a provider of outsourced coding and health information management consulting services to U.S. … Read More
NEW YORK, June 23, 2015 — MTS Health Investors, LLC (“MTS”), the New-York based healthcare private equity firm, announced today that funds managed by MTS have completed an equity investment in Ovagen Fertility (“Ovagen” or “the Company”). Ovagen is a platform of industry-leading assistive reproductive technology (“ART”) laboratories in four states performing all aspects of … Read More
NASHVILLE, Tenn., May 13, 2015 /PRNewswire/ — MDsave, the nation’s first and largest online healthcare marketplace, announced its first institutional investment of $12 million from MTS Health Investors, the New York-based private equity firm. MDsave provides cash-paying consumers with discounted access to quality healthcare providers. With the increasing prevalence of high-deductible insurance plans, this offering … Read More
(New York, NY) February 23, 2015 – MTS Health Investors, LLC (“MTS”), a leading healthcare-focused private equity firm, announced that it has completed the sale of its portfolio company, Loving Care Agency (“LCA”) and its parent holding company, to Epic Health Services Inc. Based in Hasbrouck Heights, NJ, LCA provides skilled nursing services across seven … Read More
New York, October 29, 2014 — MTS Health Investors, LLC (“MTS”), the New York based healthcare private equity firm, announced today that funds managed by MTS have completed an investment in Celerion Holdings, Inc. (“Celerion” or the “Company”). MTS has partnered with management to recapitalize the business and provide capital to support future growth. Terms … Read More
MTS Backing Will Support Growth of myNEXUS and Its Unique Care Management Solution New York and Brentwood, TN, October 24, 2014 — MTS Health Investors, LLC (“MTS”), the New-York based healthcare private equity firm, announced today that funds managed by MTS have completed a majority investment in myNEXUS, Inc. (“myNEXUS” or “the Company”). myNEXUS is … Read More
(New York, NY) September 9, 2014 – MTS Health Investors, LLC (“MTS”), a healthcare-focused private equity firm, announced that it has completed the sale of its portfolio company, Florida Gulf-to-Bay Anesthesiology Associates (“FGTBA”), to TeamHealth Holdings Inc. (NYSE:TMH). Based in Tampa, FL., FGTBA’s more than 200 physicians and certified registered nurse anesthetists manage approximately 160,000 … Read More
New York, January 31, 2013 — MTS Health Investors, LLC (“MTS”), the New-York based healthcare private equity firm, has announced the final close of its third fund. With this close, MTS collectively manages assets of over $330 million. MTS Health Investors III, LP (“MTS III”) represents MTS’s largest fund and will continue to focus on … Read More
Kindred Healthcare Signs Definitive Agreement to Acquire Senior Home Care, an MTS Health Investors and Oaktree Capital Management Portfolio Company LOUISVILLE, Ky.–(BUSINESS WIRE)–Nov. 4, 2013– Kindred Healthcare, Inc. (the “Company” or “Kindred”) (NYSE:KND) today announced that it has signed a definitive agreement to acquire Senior Home Care, Inc. (“Senior Home Care”), an MTS Health Investors … Read More
• TPG, MTS-backed company raises $235 million • IPO values company at $1.1 billion • 45 health-focused companies go public this year Shares of Surgical Care Affiliates Inc, a provider of outpatient surgery facilities, rose as much as 19 percent in their trading debut, valuing the company at about $1.08 billion, sister news service Reuters … Read More
DEERFIELD, Ill., Oct. 29, 2013 (GLOBE NEWSWIRE) — ASC Acquisition LLC (“SCA”), the parent company of Surgical Care Affiliates, LLC, today announced the pricing of its initial public offering of 9,777,778 shares of its common stock, at a price to the public of $24.00 per share. The shares will be listed on the NASDAQ Global … Read More
EDISON, N.J., Sept. 17, 2013 /PRNewswire/ — Vital Decisions, LLC, a leading provider of proprietary counseling services to individuals experiencing an advanced illness, announced today that it has appointed former U.S. Secretary of Health and Human Services Tommy G. Thompson as Chairman of its Board of Directors. Vital Decisions works in partnership with the nation’s … Read More
Hasbrouck Heights, NJ, December 18, 2012 – Loving Care Agency, Inc., a leading provider of pediatric skilled nursing and home health aide services (“Loving Care”), today announced that it has appointed Glen R. Cavallo as President and Chief Executive Officer. He succeeds Bob Creamer, who will become interim chairman. Loving Care is collectively owned by … Read More
Advanced Illness Counseling Company Expands MTS Presence in Outsourced Payor Services Sector New York, December 17, 2012 — MTS Health Investors, LLC (“MTS”), the New-York based healthcare private equity firm, announced today that funds managed by MTS have acquired a majority ownership position in Vital Decisions, LLC (“Vital Decisions”) from its founders. Vital Decisions works … Read More
320 Park Avenue 33rd Floor, New York, NY 10022
p: (212) 887-2105
e: info@windrose.com